Virax Biolabs : Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid
Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid LONDON: August 3, 2023 - Virax Biolabs Group Limited , an innovative diagnostics company...
Source: marketscreener.com